FDA Insight

Join FDA Commissioner Stephen M. Hahn, M.D. and Deputy Commissioner for Medical and Scientific Affairs Anand Shah, M.D. for their final episode of FDA Insight as they discuss FDA’s Pandemic Recovery and Preparedness Plan, or PREPP. After this episode, the program is scheduled to go on hiatus.

Frank Yiannas, FDA’s Deputy Commissioner for Food Policy and Response, joins Dr. Shah for a discussion on the New Era of Smarter Food Safety and how its blueprint impacts FDA’s COVID-19 response.

Gail Bormel from the Office of Compliance in FDA’s Center for Drug Evaluation and Research joins Dr. Shah for a discussion on drug compounding and its contribution to fighting COVID-19.

Dr. Jeffrey C. Baker, Deputy Director of the FDA’s Office of Biotechnology Products in the Center for Drug Evaluation and Research, joins Dr. Shah for a discussion on how FDA’s efforts help innovation and implementation of Advanced Manufacturing technologies regarding food and drug safety.

Dr. Anand Shah and Rear Adm. Richardae Araojo, Associate Commissioner of Minority Health, discuss the FDA’s efforts to address minority health disparities among diverse racial and ethnic populations.

Dr. Shah welcomes Dr. Janet Maynard, director of FDA’s Office of Orphan Products Development, for a discussion on the agency’s work advancing evaluation and development of products that demonstrate promise for the diagnosis and treatment of rare diseases.

Dr. Shah welcomes Dr. Suzanne Schwartz, director of FDA’s Office of Strategic Partnerships and Technology Innovation at the Center for Devices and Radiological Health, for a discussion on personal protective equipment and its critical role in helping to reduce the spread of COVID-19.

Dr. Shah welcomes Elizabeth Jungman, director of CDER’s Office of Regulatory Policy, to talk about hand sanitizers and the COVID-19 pandemic.

On this week's episode, Dr. Shah brings Dr. Peter Marks back to the show to discuss the importance of getting the flu vaccine. For more information about the flu vaccine, visit: https://www.fda.gov/flu

Dr. Peter Marks, FDA's Director of the Center for Biologics Evaluation and Research, returns for his third episode to provide an update on COVID-19 vaccines and to discuss the upcoming Vaccines and Related Biological Products Advisory Committee meeting.